DE60214867T2 - Histonedeacetylase 9 - Google Patents

Histonedeacetylase 9 Download PDF

Info

Publication number
DE60214867T2
DE60214867T2 DE60214867T DE60214867T DE60214867T2 DE 60214867 T2 DE60214867 T2 DE 60214867T2 DE 60214867 T DE60214867 T DE 60214867T DE 60214867 T DE60214867 T DE 60214867T DE 60214867 T2 DE60214867 T2 DE 60214867T2
Authority
DE
Germany
Prior art keywords
hdac9
polypeptide
nucleic acid
activity
histone deacetylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60214867T
Other languages
German (de)
English (en)
Other versions
DE60214867D1 (en
Inventor
The Institute of Cancer Research Arthur London ZELENT
The Institute of Cancer Research Kevin London PETRIE
The Institute of Cancer Research Fabien London GUIDEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research Royal Cancer Hospital
Original Assignee
Institute of Cancer Research Royal Cancer Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research Royal Cancer Hospital filed Critical Institute of Cancer Research Royal Cancer Hospital
Publication of DE60214867D1 publication Critical patent/DE60214867D1/de
Application granted granted Critical
Publication of DE60214867T2 publication Critical patent/DE60214867T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60214867T 2001-10-02 2002-10-02 Histonedeacetylase 9 Expired - Lifetime DE60214867T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0123664 2001-10-02
GBGB0123664.5A GB0123664D0 (en) 2001-10-02 2001-10-02 Histone deacetylase 9
PCT/GB2002/004455 WO2003029451A2 (en) 2001-10-02 2002-10-02 Histone deacetylase 9

Publications (2)

Publication Number Publication Date
DE60214867D1 DE60214867D1 (en) 2006-11-02
DE60214867T2 true DE60214867T2 (de) 2007-05-24

Family

ID=9923113

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60214867T Expired - Lifetime DE60214867T2 (de) 2001-10-02 2002-10-02 Histonedeacetylase 9

Country Status (7)

Country Link
US (1) US7291492B2 (enExample)
EP (1) EP1432792B1 (enExample)
JP (1) JP4383170B2 (enExample)
AT (1) ATE340257T1 (enExample)
DE (1) DE60214867T2 (enExample)
GB (1) GB0123664D0 (enExample)
WO (1) WO2003029451A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532244A4 (en) 2001-06-14 2005-12-14 Bristol Myers Squibb Co NEW HISTONIC HUMAN DEACETYLASES
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1608628A2 (en) 2003-03-17 2005-12-28 Takeda San Diego, Inc. Histone deacetylase inhibitors
GB0321694D0 (en) * 2003-09-16 2003-10-15 Ark Therapeutics Ltd Genes and their therapeutic use
WO2006066133A2 (en) 2004-12-16 2006-06-22 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
WO2008039461A2 (en) * 2006-09-27 2008-04-03 Thinsilicon Corp. Back contact device for photovoltaic cells and method of manufacturing a back contact
WO2008150769A2 (en) * 2007-05-31 2008-12-11 Thinsilicon Corporation Photovoltaic device and method of manufacturing photovoltaic devices
RU2499599C2 (ru) 2007-09-28 2013-11-27 Интрексон Корпорейшн Конструкции терапевтического переключения генов и биореакторы для экспрессии биотерапевтических молекул и их применение
WO2010011700A2 (en) 2008-07-23 2010-01-28 The Brigham And Women's Hospital, Inc. Treatment of cancers characterized by chromosomal rearrangement of the nut gene
US20100282314A1 (en) * 2009-05-06 2010-11-11 Thinsilicion Corporation Photovoltaic cells and methods to enhance light trapping in semiconductor layer stacks
WO2010144421A2 (en) * 2009-06-10 2010-12-16 Thinsilicon Corporation Photovoltaic modules and methods of manufacturing photovoltaic modules having multiple semiconductor layer stacks
US20110114156A1 (en) * 2009-06-10 2011-05-19 Thinsilicon Corporation Photovoltaic modules having a built-in bypass diode and methods for manufacturing photovoltaic modules having a built-in bypass diode
US11441672B2 (en) * 2019-10-29 2022-09-13 Lokar, Inc. Adjustable shift lever mount

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393725A1 (en) * 1999-12-08 2001-06-14 Axys Pharmaceuticals, Inc. Histone deacetylase-8 proteins, nucleic acids, and methods of use
AU2002212350A1 (en) * 2000-10-31 2002-05-15 Bayer Aktiengesellschaft Regulation of human histone deacetylase
US20040077046A1 (en) 2000-12-20 2004-04-22 Dalia Cohen Histone deacetylase-related gene and protein
EP1409661A4 (en) 2001-06-14 2006-02-01 Sloan Kettering Inst Cancer HDAC9 POLYPEPTIDES, POLYNUCLEOTIDES AND USES THEREOF
EP1532244A4 (en) 2001-06-14 2005-12-14 Bristol Myers Squibb Co NEW HISTONIC HUMAN DEACETYLASES

Also Published As

Publication number Publication date
JP4383170B2 (ja) 2009-12-16
EP1432792A2 (en) 2004-06-30
DE60214867D1 (en) 2006-11-02
US7291492B2 (en) 2007-11-06
US20050130146A1 (en) 2005-06-16
JP2005503824A (ja) 2005-02-10
WO2003029451A3 (en) 2003-08-21
GB0123664D0 (en) 2001-11-21
WO2003029451A2 (en) 2003-04-10
EP1432792B1 (en) 2006-09-20
ATE340257T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
DE69631540T2 (de) Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs-suszeptilitaetsgens brca2 und dessen anwendungen
DE3750738T2 (de) Menschliche DNS für die Diagnose von Glioma-retinae.
DE69836131T3 (de) Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
DE60214867T2 (de) Histonedeacetylase 9
DE69831222T2 (de) Verbindungen zur immundiagnose von prostatakrebs und deren verwendung
DE69521002T3 (de) Mutationen des mit 17q verbundenen Ovarial- und Brustkrebs Empfindlichkeitsgens
DE68928491T2 (de) Erzeugnisse und verfahren zur regelung der suppression von neoplastischen phenotypen
DE69531892T2 (de) Fibroblasten-wachstumsfaktor 10
EP2290104A2 (de) Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
DE69433940T2 (de) Menschliches mutator-gen nmsh2 und seine verbindung zum hereditaren, nichtpolypösen kolorrektalen karzinom
DE69633272T2 (de) Methoden zur Krebsbehandlung und -kontrolle
DE69020018T2 (de) Gentechnologische menschliche Cholinesterasen.
DE60032910T3 (de) Mittel zum nachweis und zur behandlung von krankheiten die in verbindung stehen mit fgfr3
EP0613497B1 (de) Lymphoides cd30-antigen
DE69631041T2 (de) Promotor des utrophingens
DE60029624T2 (de) Homologe enzyme der humanen heparanase sowie alternative spleissformen davon
DE69813194T2 (de) Assay, verbindungen, therapie und nachweisverfahren um zelluläre dns-reparatur-aktivität zu modulieren
DE60024862T2 (de) "insulinabhängiges sequenz dna bindendes protein-1" (irsdbp-1), dafür kodierendes gen und ihre verwendungen
DE10118452A1 (de) Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse
WO2007068449A2 (de) Molekulare marker für eine tumordiagnose und -therapie
DE19958680A1 (de) cDNA-Sequenzen von zwei Interaktoren FANCIP4 und FANCIP5 der Fanconi-Anämie-Pr oteine der Komplementationsgruppen A und C
WO2000046244A1 (de) cDNA-SEQUENZ EINES INTERAKTORS FANCIP1 DES FANCONI-ANÄMIE-PROTEINS DER KOMPLEMENTATIONSGRUPPE A
WO2001012818A1 (de) Neutrale hirn-sphingomyelinase
HK1111734A (en) Transcription factor islet-brain 1(ib1)
DE19929887A1 (de) cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A

Legal Events

Date Code Title Description
8364 No opposition during term of opposition